Market Research Future Predicts the Global Healthcare Cold Chain Logistics Market to Attain a 7.54% CAGR During 2017-2023

Healthcare Cold Chain Logistics Market Size, Share, Growth, Global Analysis, Trends Information by Product type (Biopharmaceuticals, Vaccines, Clinical Trial Materials and Others), Services (Storage, Transportation, Packaging and Others), Storage Techniques (Electrical refrigeration, Dry Ice, Gel Packs, Liquid nitrogen and Others), By Region (North America, Europe, Asia Pacific, The Middle East & Africa (MEA) and Latin America) – Global Forecast by 2023

Market Synopsis:

The pharmaceutical industry is expanding at a substantial rate creating immense opportunity for the healthcare cold chain logistics market to proliferate. Personalized drugs and other thermolabile pharmaceutical products like vaccination requires uninterrupted refrigeration to protect from fluctuating temperature conditions during transportation. Cold chain logistics plays a pivotal role in maintaining the potency of those healthcare products during transportation until administered to the targeted end users.

Demand for cold chain logistics in the healthcare sector is increasing with time and the global Healthcare Cold Chain Logistics Market is expected to grow with a 7.54% CAGR during the forecast period 2018-2023 predicts Market Research Future (MRFR).

The rise in number of clinical research cases is likely to shoot up the growth curve of the market. Although cold chain logistics is contributing largely to safe delivery and distribution of temperature-sensitive products which is the major factor propelling the global healthcare cold chain logistics market there are challenges which are likely to halt the market growth. Loopholes in regulatory standards for healthcare cold chain logistics and improper management disrupting the flow of logistics operations are anticipated to interfere the market expansion. 

Key players:

·         AmerisourceBergen Corporation

·         American Airlines

·         DB Schenker

·         FedEx

·         Marken

·         Cavalier Logistics

·         KUEHNE + NAGEL

·         DHL international GmbH

Segmental Analysis:

·         The MRFR report includes a detailed segmental analysis of the market based on product type, storage techniques, end user and services.

·         Based on product type, the healthcare cold chain logistics market is segmented into clinical trial materials, vaccines, biopharmaceuticals, and others.

·         Based on product type, the market has been segmented into clinical trial materials, vaccines, biopharmaceuticals, and others.

·         Based on services, the market has been segmented into packaging, transportation, storage and others

·         Based on storage techniques, the market has been segmented into liquid nitrogen, electrical refrigeration, gel packs, dry ice and others.

·         Based on end user, the market has been segmented into research institutes, hospitals and clinics, biopharmaceutical companies, and others. The biopharmaceutical segment is expected to grow with the highest CAGR during the forthcoming period.

Regional Analysis:

Based on region the market has been segmented into North America, Asia Pacific (APAC), Europe and the Middles East and Africa (MEA). North America is anticipated to augment the market growth owing to increasing advancements in the pharmaceutical sector and numerous service providers in the region. Followed by Latin America the Asia Pacific and European regions to experience market expansion followed by Latin America.

Industry Update

April 2019: Tata Motors recently invested in a pharmaceutical cold chain specialist, Kool-ex, is experiencing substantial growth. Owing to the increasing demand for cold chain logistics in the pharma sector, Tata Motors is planning to invest Rs 140 crore in the next two years to double its fleet to 800 reefer trucks